Education:
`Ph.D. in Organic Chemistry, Purdue University, West Lafayette, IN (2000-2005)
`• Research Advisor: Mark A. Lipton, Associate Professor of Chemistry
`• Dissertation: Part I. Design and Synthesis of Ureidopeptides as Protease Inhibitors, Part II. Novel
`Synthesis of a Fluorescent Coumaryl Amino Acid
`• Cumulative graduate GPA: 3.65
`
`
`B.S. in Honors Chemistry and Biochemistry, Purdue University, West Lafayette, IN (1996-2000)
`• Minor in French
`• Undergraduate Research Advisor: Mark A. Lipton, Associate Professor of Chemistry
`• Cumulative undergraduate GPA: 3.72
`
`Adam C. Myers, Ph.D.
`Adam.Myers@amriglobal.com
`3065 Kent Avenue
`West Lafayette, IN 47906
`765-463-0112 x3861
`
`
`Work Experience:
`SSCI, a Division of Albany Molecular Research, Inc. (AMRI), West Lafayette, IN (July 2014-present)
`• Senior Research Investigator – Preformulation (October 2015 to present)
`• Research Investigator – Preformulation (July 2014 to September 2015)
`o Perform independently hands-on experimental work utilizing chromatography, mass
`spectrometry, UV-Vis, dissolution, and other analytical techniques in a cGMP laboratory
`setting.
`o Provide project oversight, client interactions, and scientific input.
`o Conduct scheduled preventive maintenance and qualification of equipment.
`o Develop and write analytical methods and operating procedures according to specific
`sample or testing requirements.
`o Participate in troubleshooting of analytical test methods and laboratory instruments.
`o Prepare experimental protocols and interim and final reports.
`o Participate in business development including preparation of client proposals and quotes.
`BASi, West Lafayette, IN (November 2007-July 2014)
`• Senior Scientist/Team Leader (January 2014 to July 2014)
`• Director Pharmaceutical Scientific Operations (August 2012 to January 2014)
`o Provide leadership to a lab conducting both cGMP and GLP projects. Responsible for
`projects from initial client interaction through completion.
`o Develop, document, and validate protocols, method, and techniques for release, stability,
`in vitro bioequivalence, comparative binding, and toxicology dose formulation analysis
`testing using a variety of analytical techniques, including HPLC (UV, fluorescence, and
`electrochemical detection), IC, Dissolution, Particulate Matter, Karl Fisher, Polarographic
`Analysis, GC, and a variety of compendial testing techniques. Products analyzed include
`traditional dosing forms as well as drug-coated devices.
`o Oversee purchase, installation, verification, and training on new analytical
`instrumentation.
`o Provide technical advice to laboratory staff and troubleshoot laboratory issues.
`o Create and maintain templates for protocols, methods, reports, and other project-related
`documents.
`o Conduct business development activities for pharmaceutical analysis department.
`o
`Interact with current and potential clients to evaluate new business requests relative to
`internal capabilities, scope of the project, and business viability. Travel to visit potential
`and existing customers.
`
`SENJU EXHIBIT 2127
`LUPIN v SENJU
`IPR2015-01105
`
`PAGE 1 OF 5
`
`

`
`o Work closely with QA to ensure proper regulatory compliance for laboratory operations.
`Serve as the primary technical representative for client and regulatory agency audits.
`Conduct audits of sub-contractor laboratories.
`o Coordinate with metrology to schedule instrument verification, maintenance, and repair.
`o Develop and maintain records to comply with appropriate regulatory requirements.
`o Supervise all pharmaceutical analysis laboratory staff, ensuring proper training and
`staffing resources. Schedule project work for the laboratory. Coordinate borrowed
`resources from other departments to ensure project completion.
`o Serve as administrator for corporate chromatography software.
`o Serve as primary safety trainer for corporate chemical safety.
`• Assistant Director, Pharmaceutical Analysis (February 2012 to August 2012)
`o Provided scientific direction to a lab conducting both cGMP and GLP projects.
`Responsible for projects from assignment through completion.
`o Developed, documented, and validated protocols, methods, and techniques for release,
`stability, in vitro bioequivalence, and toxicology dose formulation analysis testing using a
`variety of analytical techniques, including HPLC (UV, fluorescence, and electrochemical
`detection), IC, Dissolution, GC, Particulate Matter, Karl Fisher, Polarographic Analysis,
`and a variety of compendial testing techniques. Products include traditional dosing forms
`as well as drug-coated devices.
`o Participated in purchase, installation, verification, and training on new analytical
`instrumentation.
`o Provided technical advice to laboratory staff and troubleshoot laboratory issues.
`Conducted laboratory work as needed, focused primarily on development activities.
`o Created and maintained templates for protocols, methods, reports, and other project-
`related documents.
`Interacted with current and potential clients, in coordination with department director, to
`evaluate new business requests relative to internal capabilities, scope of the project, and
`business viability. Traveled to visit potential and existing customers.
`o Worked closely with QA to ensure proper regulatory compliance for laboratory
`operations. Served as a technical representative for client and regulatory agency audits.
`Conducted audits of sub-contractor laboratories.
`o Developed and maintained records to comply with appropriate regulatory requirements.
`o Supervised all pharmaceutical analysis laboratory staff, ensuring proper training and
`staffing resources. Scheduled project work for the laboratory.
`o Served as back-up administrator for corporate chromatography software.
`o Served on chemical safety committee.
`• Senior Scientist/Team Leader (November 2007-January 2012)
`o Developed, documented, and validated protocols, methods, and techniques for release,
`stability, in vitro bioequivalence, and toxicology dose formulation analysis testing using a
`variety of analytical techniques, including HPLC (UV, fluorescence, and electrochemical
`detection), IC, Dissolution, GC, Particulate Matter, Karl Fisher, Polarographic Analysis,
`and a variety of compendial testing techniques.
`o Direct analysis of pharmaceutical products in a cGMP setting, as well as for GLP
`toxicology dosing samples. Sample types range from traditional dosing forms as well as
`drug-coated devices.
`o Prepared, edited, and approved project reports.
`o Maintained and developed client relationships.
`o
`Introduced new equipment to the company and conducted qualification on that
`equipment.
`o Back-up administrator for corporate chromatography software
`o Served on chemical safety committee.
`
`o
`
`
`Quadraspec, Inc., West Lafayette, IN (February 2006-September 2007)
`• Senior Manufacturing Chemist (February 2006-September 2007)
`o Developed functional surface chemistries as platforms for protein micro-arrays used in
`diagnostic assay development. Efforts included design and synthesis (including
`
`PAGE 2 OF 5
`
`

`
`anhydrous techniques), analysis by HLPC, GC, Fluorescence, Interferometry,
`Goniometry, NMR, and FT-IR.
`o Conducted product transfer from development into cGMP manufacturing, including
`optimization for manufacturability.
`o Worked on product costing (labor and materials) and contributed to company cost-
`reduction efforts through chemical process improvements to manufacturing.
`o Coordinated supply and scheduling of multi-step chemical manufacturing processes,
`servicing multiple internal and external customers.
`o Supervised and trained a team of 7 manufacturing chemists and interns to produce
`diagnostic devices in a GMP manufacturing setting.
`o Served on interdisciplinary task forces for short-term projects.
`o Evaluated and qualified vendors, including site audits.
`o Conducted and supervised IQ/OQ/PQ of manufacturing equipment, as well as routine
`maintenance. This included maintenance and selection of company DI water systems.
`o Extensive documentation experience including Standard Operating Procedures and
`Batch Production Records
`o Contributed to patent writing and research for chemical applications, including extensive
`literature research.
`o Managed laboratory and facility renovation and improvement projects for the
`manufacturing spaces of the company, including clean room spaces.
`• Chemical Safety Officer (February 2006-September 2007)
`o Designed and implemented the entire company safety system in compliance with OSHA,
`EPA, and DOT regulations. Wrote all documentation for emergency and safety
`procedures.
`o Designed and conducted chemical safety training for all employees, including initial and
`remedial training, as well as regular updates.
`o Conducted laboratory audits and remediation.
`o Sole responsibility for chemical waste handling, removal, and compliance.
`o Supervised area safety representatives from 8 departments.
`o Coordinated company PPE purchasing and service.
`o Coordinated all company access control.
`o Served on the company Change Control Board, reviewing all SOPs and other documents
`governed by good documentation practices.
`
`
`Purdue University, West Lafayette, IN (August 2000 to December 2005)
`• Graduate Assistant, Department of Chemistry
`o Synthesis of pseudopeptide protease inhibitors for HIV-1 and SARS
`o Synthesis of coumaryl amino acids
`o Biological assays of HIV-1 protease inhibition
`o Used multiple analytical instruments including HPLC, MS, and NMR
`o Financial management of research funds while advisor was on sabbatical
`o Taught undergraduate organic laboratories and assisted a graduate organic
`spectroscopy course
`o Supervised undergraduate researchers
`
`
`Eli Lilly and Company (Summers 1998, 1999, and 2000)
`•
`Intern, Chemical Process Research and Development, Indianapolis, IN (Summer 2000)
`o Supervisor: Dr. Tony Zhang
`o Conducted methodology development screening organo-metallic catalysts using parallel
`reactors
`Intern, Research Records, Greenfield, IN (Summer 1998 and Summer 1999)
`o Supervisor: Dr. Richard J. Loncharich
`o Supervised statistical sampling of corporate archives for compound degradation
`o Assisted in selection of third party compounds for acquisition
`o Chemical structure data and maintenance in corporate registration database. Skills
`include ISIS Draw, ISIS Base.
`
`•
`
`PAGE 3 OF 5
`
`

`
`
`Publications:
`• Barth, Benjamin S.; Myers, Adam C.; Lipton, Mark A. Exploring The Stereochemical
`Requirements For Protease Inhibition By Ureidopeptides, Journal of Peptide Research. 2005,
`65(3), 352-354.
`• Myers, Adam C.; Kowalski, Jennifer A.; Lipton, Mark A. Facile Incorporation of Urea
`Pseudopeptides into Protease Substrate Analogue Inhibitors, Bioorganic and Medicinal
`Chemistry Letters. 2004, 14, 5219-5222.
`
`
`Presentations, Lectures, and Conferences:
`Selected Oral Presentations
`• Myers, Adam C. Start-ups and research parks: Springboards to your chemical career. Oral
`Presentation, 250th ACS National Meeting, Boston, MA, August 16-20, 2015.
`• Myers, Adam C. Career Preparation from the Laboratory and Beyond. Oral Presentation,
`Chemistry Department Freshman Seminar, Purdue University, West Lafayette, IN, December 1,
`2014 and February 24, 2015.
`• Myers, Adam C.; Spann, Teresa. Revised chromatographic determination of Gentamicin
`content in conformity with the August revision of the USP. Oral Presentation, 246th ACS
`National Meeting, Indianapolis, IN, September 8-12, 2013.
`• Myers, Adam C. Career Preparation from Beyond the Laboratory. Oral Presentation,
`Chemistry Department Freshman Seminar, Purdue University, West Lafayette, IN, February 19,
`2013.
`• Myers, Adam C. ACS and the YCC. Oral Presentation, ACS Leaders Conference, Dallas, TX,
`January 25, 2013.
`• Myers, Adam C. Contract Research at BASi: Partnering with Pharma and Career
`Opportunities. Oral Presentation. Chemistry Department Colloquium, Valparaiso University,
`Valparaiso, IN, September 21, 2012.
`• Myers, Adam C. Chemical Career Strategies: Maximizing Your Toolbox. Oral Presentation.
`St. Louis Younger Chemists Committee Seminar, Washington University, St. Louis, MO, February
`23, 2012.
`• Myers, Adam C. But that wasn’t my research area. Oral Presentation. 242nd ACS National
`Meeting, Denver, CO, August 28-September 1, 2011.
`• Myers, Adam C. BASi: 1974 to the Present. Oral Presentation. 42nd Meeting of the ACS Central
`Region, Indianapolis, IN, June 8-10, 2011.
`• Myers, Adam C. Chart your career course by filling your toolbox. Oral Presentation. 241st
`ACS National Meeting, Anaheim, CA, March 27-31, 2011.
`• Myers, Adam C. Career Preparation From Beyond the Laboratory. Oral Presentation. 234th
`ACS National Meeting, Boston, MA, August 19-23, 2007.
`• Myers, Adam C.; Lipton, Mark A. Role of ureidopeptides in protease inhibition. Oral
`Presentation. 228th ACS National Meeting, Philadelphia, PA, August 22-26, 2004.
`• Myers, Adam C.; Lipton, Mark A. Synthesis of a novel ureidopeptide inhibitor of HIV-1
`protease. Oral Presentation. 225th ACS National Meeting, New Orleans, LA, March 23-27, 2003.
`• Myers, Adam C. A Proposed Total Synthesis of Nomofungin. Oral Presentation, Organic
`Division Original Proposal, Purdue University, West Lafayette, IN, January 2003.
`Selected Poster Presentations
`• Zhao, Yinyan; Gasaway, Annalise; Myers, Adam C. Application of a Gradient HPLC-UV
`Method for In Vitro Bioequivalence Assessment of Colesevelam Hydrochloride Tablet
`Formulations in Simulated Intestinal Fluid. Poster Presentation. AAPS National Meeting, San
`Antonio, TX, November 10-14, 2013.
`• Myers, Adam C.; Ludwig, Josef K.; Sassman, Jennifer L.; Henry, Jonathan W.; Zhao, Yinyan.
`Method development for equilibrium and kinetic binding in vitro bioequivalence of
`Colesevelam Hydrochloride in simulated intestinal fluid (SIF). Poster Presentation. 243rd
`ACS National Meeting, San Diego, CA, March 25-29, 2012.
`
`PAGE 4 OF 5
`
`

`
`• Bannochie, Christopher J.; Myers, Adam C; Crawford, John C. Subdivisions: Creating diversity
`within the Division of Professional Relations. Poster Presentation, 240th ACS National
`Meeting, Boston, MA, August 22-26, 2010.
`• Myers, Adam C.; Lipton, Mark A. Synthesis of a novel ureidopeptide inhibitor of HIV-1
`protease. Poster Presentation. 38th National Organic Symposium, Bloomington, IN, June 2003
`
`•
`
`•
`•
`
`
`Continuing Education, Scientific and Professional Conferences:
`•
`“Leading Change”, ACS Leadership Institute, Dallas, TX, January 26, 2013.
`•
`“Collaborating Across Boundaries”, ACS Leadership Institute, Fort Worth, TX, January 21, 2012.
`•
`“EC-1 Principles and Application of Electroanalytical Chemistry”, BASi EC Training Workshop,
`West Lafayette, IN, March 8-9, 2011.
`“Engaging and Motivating Volunteers”, ACS Leadership Institute, Fort Worth, TX, January 23,
`2010.
`“Strategic Planning”, ACS Leadership Institute, Fort Worth, TX, January 23, 2010.
`“Analytical Method Transfer of Pharmaceutical Products”, ACS Short Course, Washington, D.C.,
`August 18, 2009.
`“Fostering Innovation”, ACS Leadership Institute, Fort Worth, TX, January 24, 2009.
`“Coaching and Feedback”, ACS Leadership Institute, Fort Worth, TX, January 24, 2009.
`
`•
`•
`
`
`Scientific and Professional Affiliations:
`• American Chemical Society (ACS), 2000-Present
`o Purdue Local Section Chair, 2011 – present
`o Purdue Local Section Vice Chair, 2006 – 2010
`o Organizer, Small Chemical Business in the Purdue Research Park, September 2006
`• ACS Division of Professional Relations, 2007 – Present
`o Chair, Young Chemists Subdivision, 2014
`o Chair-Elect, Young Chemists Subdivision, 2013
`o Member-at-Large, 2011 – 2012
`o Past-Chair, 2010
`o Chair, 2009
`o Chair-Elect, 2008
`o Chair and Organizer, multiple symposia at national ACS meetings
`• ACS Committee on Science, 2013 – Present
`• ACS Younger Chemists Committee (YCC), 2001 – 2012
`o National Meeting Activities (NMA) Subcommittee Chair, 2004 – 2008
`o Program Chair, 2004 – 2007, 2011 – 2012
`o Programming Cosponsorship Coordinator, 2001 – 2004
`o Chair and Organizer, multiple symposia at national ACS meetings
`• Graduate Student Advisory Board, Department of Chemistry, Purdue University, 2003 – 2005
`o Co-Chair, 2004 – 2005
`o Organizer, departmental colloquium
`• Purdue University College of Science Alumni Board, Purdue University, 2001 – 2009
`o President, 2006 – 2008
`o Vice President, 2005 – 2006
`
`PAGE 5 OF 5